In a filing, Amneal Pharmaceuticals Inc revealed its Executive Vice President Shah Nikita unloaded Company’s shares for reported $0.67 million on Aug 14 ’25. In the deal valued at $9.29 per share,71,694 shares were sold. As a result of this transaction, Shah Nikita now holds 267,235 shares worth roughly $2.49 million.
Then, Konidaris Tasos sold 219,159 shares, generating $2,066,669 in total proceeds. Upon selling the shares at $9.43, the Executive Vice President & CFO now owns 122,152 shares.
Before that, Konidaris Tasos sold 161,365 shares. Amneal Pharmaceuticals Inc shares valued at $1,487,785 were divested by the Executive Vice President & CFO at a price of $9.22 per share. As a result of the transaction, Konidaris Tasos now holds 460,517 shares, worth roughly $4.3 million.
Goldman initiated its Amneal Pharmaceuticals Inc [AMRX] rating to a Buy in a research note published on June 06, 2025; the price target was $12. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in late February from “a Neutral” to “an Overweight”. JP Morgan also remained covering AMRX and has increased its forecast on September 06, 2024 with a “Neutral” recommendation from previously “an Underweight” rating.
Price Performance Review of AMRX
On Tuesday, Amneal Pharmaceuticals Inc [NASDAQ:AMRX] saw its stock jump 0.76% to $9.33. Over the last five days, the stock has gained 3.44%. Amneal Pharmaceuticals Inc shares have risen nearly 17.95% since the year began. Nevertheless, the stocks have risen 17.80% over the past one year. While a 52-week high of $9.59 was reached on 08/15/25, a 52-week low of $6.68 was recorded on 04/10/25.
Levels Of Support And Resistance For AMRX Stock
The 24-hour chart illustrates a support level at 9.24, which if violated will result in even more drops to 9.16. On the upside, there is a resistance level at 9.39. A further resistance level may holdings at 9.45.
How much short interest is there in Amneal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc stocks on 2025-07-31, dropping by -1.63 million shares to a total of 4.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 6.55 million shares. There was a decline of -32.99%, which implies that there is a negative sentiment for the stock.
